Transport of drugs from blood vessels to tumour tissue, Nat. Rev. Canc, vol.17, pp.738-750, 2017. ,
Normalization of the vasculature for treatment of cancer and other diseases, Physiol. Rev, vol.91, pp.1071-1121, 2011. ,
Heterogeneity of the tumor vasculature, Semin. Thromb. Hemost, vol.36, pp.321-331, 2010. ,
Reengineering the tumor microenvironment to alleviate hypoxia and overcome cancer heterogeneity, Cold Spring Harbor Perspect, 2016. ,
Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability, Nat. Rev. Canc, vol.8, pp.180-192, 2008. ,
Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy, Science, vol.307, pp.58-62, 2005. ,
, Compensatory angiogenesis and tumor refractoriness, vol.4, p.153, 2015.
Lessons from phase III clinical trials on anti-VEGF therapy for cancer, Nature clinical practice, Oncology, vol.3, pp.24-40, 2006. ,
Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway, Cancer Cell, vol.21, pp.66-81, 2012. ,
Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis, Cancer Cell, vol.15, pp.232-239, 2009. ,
Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2, Cell Rep, vol.10, pp.1066-1081, 2015. ,
Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis, Cancer Cell, vol.15, pp.220-231, 2009. ,
Anti-angiogenic agents for the treatment of solid tumors: potential pathways, therapy and current strategies -a review, J. Adv. Res, vol.8, pp.591-605, 2017. ,
Anti-angiogenesis or proangiogenesis for cancer treatment: focus on drug distribution, Int. J. Clin. Exp. Med, vol.8, pp.8369-8376, 2015. ,
The optimal utilization proportion of external beam radiotherapy in European countries: an ESTRO-HERO analysis, Radiotherapy and oncology, J. Eur. Soc. Ther. Radiol. Oncol, vol.116, pp.38-44, 2015. ,
, Tumor response to radiotherapy regulated by endothelial cell apoptosis, vol.300, pp.1155-1159, 2003.
Improved functionality of the vasculature during conventionally fractionated radiation therapy of prostate cancer, PLoS One, vol.8, p.84076, 2013. ,
Real-time visualization and quantitation of vascular permeability in vivo: implications for drug delivery, PLoS One, vol.7, p.33760, 2012. ,
Distribution of the anticancer drugs doxorubicin, mitoxantrone and topotecan in tumors and normal tissues, Cancer Chemother. Pharmacol, vol.72, pp.127-138, 2013. ,
Tumor vessel normalization by the PI3K inhibitor HS-173 enhances drug delivery, Cancer Lett, vol.403, pp.339-353, 2017. ,
Modulation of the tumor microvasculature by phosphoinositide-3 kinase inhibition increases doxorubicin delivery in vivo, Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res, vol.18, pp.161-169, 2012. ,
American Association of Physicists, AAPM protocol for 40-300 kV x-ray beam dosimetry in radiotherapy and radiobiology, Med. Phys, vol.28, pp.868-893, 2001. ,
PM : an international journal devoted to the applications of physics to medicine and biology, Off. J. Ital. Assoc. Biomed. Phys, vol.30, pp.63-68, 2014. ,
Sunitinib treatment does not improve blood supply but induces hypoxia in human melanoma xenografts, BMC Canc, vol.12, p.388, 2012. ,
In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and plateletderived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship, Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res, vol.9, pp.327-337, 2003. ,
Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer, Radiat. Oncol, vol.7, p.154, 2012. ,
Use of molecular biomarkers to quantify the spatial distribution of effects of anticancer drugs in solid tumors, Mol. Cancer Ther, vol.12, pp.542-552, 2013. ,
Radiation improves the distribution and uptake of liposomal doxorubicin (caelyx) in human osteosarcoma xenografts, Cancer Res, vol.64, pp.547-553, 2004. ,
Enhancement of monoclonal antibody uptake in human colon tumor xenografts following irradiation, Cancer Res, vol.50, pp.159-163, 1990. ,
MRI of tumor angiogenesis, J. Magn. Reson. Imaging : JMRI, vol.26, pp.235-249, 2007. ,
Evaluation of tumor hypoxia prior to radiotherapy in intermediate-risk prostate cancer using (18)F-fluoromisonidazole PET/CT: a pilot study, Oncotarget, vol.9, pp.10005-10015, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-01823478
Vascular permeability and hyperpermeability in a murine adenocarcinoma after fractionated radiotherapy: an ultrastructural tracer study, Histochem. Cell Biol, vol.114, pp.259-275, 2000. ,
Vivo imaging reveals significant tumor vascular dysfunction and increased tumor hypoxia-inducible factor-1alpha expression induced by high single-dose irradiation in a pancreatic tumor model, Int. J. Radiat. Oncol. Biol. Phys, vol.97, pp.184-194, 2017. ,
Radiotherapy decreases vascular density and causes hypoxia with macrophage aggregation in TRAMP-C1 prostate tumors, Clin. Cancer Res. : Off. J. Am. Assoc. Cancer Res, vol.15, pp.1721-1729, 2009. ,
Ablative hypofractionated radiotherapy normalizes tumor vasculature in lewis lung carcinoma mice model, Radiat. Res, vol.179, pp.458-464, 2013. ,
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels, Nat. Commun, vol.4, p.2516, 2013. ,
Interstitial fluid pressure in tumors: therapeutic barrier and biomarker of angiogenesis, Future Oncol, vol.4, pp.793-802, 2008. ,
Combination of vessel-targeting agents and fractionated radiation therapy: the role of the SDF-1/ CXCR4 pathway, Int. J. Radiat. Oncol. Biol. Phys, vol.86, pp.777-784, 2013. ,
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases, Cancer Cell, vol.6, pp.553-563, 2004. ,
, Dev. Biol, vol.427, pp.6-11, 2017.
Microvascular mural cell organotypic heterogeneity and functional plasticity, Trends Cell Biol, vol.28, issue.4, pp.302-316, 2018. ,
Dynamic remodeling of pericytes in vivo maintains capillary coverage in the adult mouse brain, Cell Rep, vol.22, pp.8-16, 2018. ,
Regional blood flow in the normal and ischemic brain is controlled by arteriolar smooth muscle cell contractility and not by capillary pericytes, Neuron, vol.87, pp.95-110, 2015. ,
Blocking SDF-1alpha/CXCR4 downregulates PDGF-B and inhibits bone marrow-derived pericyte differentiation and tumor vascular expansion in Ewing tumors, Mol. Cancer Ther, vol.13, pp.483-491, 2014. ,
, Cancer Letters, vol.457, pp.1-9, 2019.